SI090060: Ixazomib-d9 Pack Size:5 mg 35 / An α-D-N-acetylgalactosamine (GalNAcα)

35 / An α-D-N-acetylgalactosamine (GalNAcα) ligand equipped with a methyl ester-protected carboxylic acid through a short butyl spacer

/ α-D-GalNAc-Butyl-Carboxylic Acid / α-GalNAc-Bu-COOH

/ Tris-GalNAc-β-Ala-PEG3-FITC / Triantennary β-D-GalNAc-β-Alanine-PEG3-FITC

45 / Diabetes Type 2 / Nateglinide-d5 / N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine-d5

2-[2-(2-Azidoethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-β-D-galactopyranoside

SI090060: Ixazomib-d9 Pack Size:5 mg 35 / An α-D-N-acetylgalactosamine (GalNAcα)C14H10D9BCl2N2O4 370. 08 Lung Cancer Ixazomib d9 Ninlaro d9; N2 (2,5 Dichlorobenzoyl) N [(1R) 1 (dihydroxyboryl) 3 methylbutyl]glycinamide d9